Biopharma | June 05, 2026
Aurobindo Pharma launches TheraNym, India’s largest biologics CMO
MSD joins as anchor customer as Aurobindo strengthens its position in the fast-growing global biologics manufacturing market
MSD joins as anchor customer as Aurobindo strengthens its position in the fast-growing global biologics manufacturing market
He has successfully led the development of 15 approved drugs worldwide across various therapeutic areas over his more than 20-year career
Nanomi's pioneering approach in drug delivery has set new benchmarks in the industry, and this award serves as a motivation to continue its mission to revolutionize healthcare
This two-day program was attended by 40 doctors & paramedical staff
CMOs showed an increasing reluctance to take on debt in 2022
This loan is in addition to earlier announced CAD 25 million loan committed by the Province of Quebec
The company sees the business reaching $100mn
Guindo will be responsible for leading the development and implementation of the company’s long-term strategy for the Human Health portfolio.
Follows Zealand Pharma’s appointment of Adam Steensberg as CEO and decision to refocus strategy
Patient with acute Covid-19 infection treated at BGS Gleneagles Global Hospital
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
